デフォルト表紙
市場調査レポート
商品コード
1714381

医薬品用ゼラチン市場- 世界の産業規模、シェア、動向、機会、予測、タイプ別、供給源別、機能別、エンドユーザー別、地域別、競合市場別、2020-2030年

Pharmaceutical Gelatin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Source, By Function, By End User, By Region and Competition, 2020-2030F

出版日
ページ情報
英文 181 Pages
納期
2～3営業日
カスタマイズ可能
医薬品用ゼラチン市場- 世界の産業規模、シェア、動向、機会、予測、タイプ別、供給源別、機能別、エンドユーザー別、地域別、競合市場別、2020-2030年
出版日: 2025年04月25日
発行: TechSci Research
ページ情報: 英文 181 Pages
納期: 2～3営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 目次
概要

医薬品用ゼラチンの世界市場は、2024年に18億9,000万米ドルと評価され、2030年にはCAGR 5.51%を記録して26億1,000万米ドルに達すると予測されています。

医薬品用ゼラチンは、その生体適合性と厳格な安全性および純度基準を満たす能力により、カプセル、錠剤、止血剤などの医薬品製剤に広く使用されている重要な賦形剤です。動物性コラーゲンを主原料とする医薬品用ゼラチンは、病原体、アレルゲン、有害物質を含まないことを保証するために、滅菌、精製などの厳格な処理が施されています。薬剤の安定性、生物学的利用能、患者のコンプライアンスを向上させる一貫した性能により、様々な治療用途において不可欠なものとなっています。地域的な嗜好や規制ガイドラインによって、ゼラチンの原料が牛、豚、魚、鶏のいずれであるかが決まることが多いです。経口剤形に対する需要の高まりは、医薬品製造の技術的進歩と相まって、世界の市場拡大を後押しし続けています。

市場概要
予測期間 2026-2030
市場規模：2024年 18億9,000万米ドル
市場規模：2030年 26億1,000万米ドル
CAGR：2025年～2030年 5.51%
急成長セグメント ソフトカプセル
最大市場 北米

市場促進要因

製薬業界の成長

主な市場課題

原料供給と価格変動

主な市場動向

植物ベースの代替品へのシフト

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の医薬品用ゼラチン市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • タイプ別（A型、B型）
    • 原料別（豚、牛皮、牛骨、魚、鶏肉）
    • 機能別（安定化、増粘、ゲル化、その他）
    • エンドユーザー別（ハードカプセル、ソフトカプセル、タブレット、吸収性止血材、その他）
    • 企業別（2024）
    • 地域別
  • 市場マップ

第6章 北米の医薬品用ゼラチン市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 北米：国別分析
    • 米国
    • メキシコ
    • カナダ

第7章 欧州の医薬品用ゼラチン市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 欧州：国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋地域の医薬品用ゼラチン市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • アジア太平洋地域：国別分析
    • 中国
    • インド
    • 韓国
    • 日本
    • オーストラリア

第9章 南米の医薬品用ゼラチン市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの医薬品用ゼラチン市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 中東・アフリカ：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 合併と買収
  • 製品上市
  • 最近の動向

第13章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第14章 競合情勢

  • Gelita AG
  • Trobas Pharmaceutical gelatine B.V
  • Rousselot SAS
  • Gelatines Weishardt SAS
  • Sterling Biotec Ltd.
  • Catalent, Inc
  • Nitta Pharmaceutical Gelatin India Limited
  • Aspire Pharmaceuticals
  • Gelco International
  • Lapi Gelatine S.p.a

第15章 戦略的提言

第16章 調査会社について・免責事項

目次
Product Code: 15739

The Global Pharmaceutical Gelatin Market was valued at USD 1.89 billion in 2024 and is projected to reach USD 2.61 billion by 2030, registering a CAGR of 5.51%. Pharmaceutical gelatin is a critical excipient widely used in drug formulations such as capsules, tablets, and hemostats due to its biocompatibility and ability to meet stringent safety and purity standards. Derived primarily from animal collagen, pharmaceutical gelatin undergoes rigorous processing, including sterilization and purification, to ensure it is free from pathogens, allergens, and harmful substances. Its consistent performance in enhancing drug stability, bioavailability, and patient compliance makes it indispensable across various therapeutic applications. Regional preferences and regulatory guidelines often dictate the source of gelatin-whether bovine, porcine, fish, or poultry. The growing demand for oral dosage forms, coupled with technological advances in pharmaceutical manufacturing, continues to propel market expansion globally.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.89 Billion
Market Size 2030USD 2.61 Billion
CAGR 2025-20305.51%
Fastest Growing SegmentSoft Capsule
Largest MarketNorth America

Key Market Drivers

Growing Pharmaceutical Industry

The expanding pharmaceutical sector is a primary driver of the pharmaceutical gelatin market, with increasing demand for effective and patient-friendly dosage forms such as capsules. Gelatin plays a vital role in improving drug solubility, enabling controlled drug release, and enhancing the overall stability of active pharmaceutical ingredients (APIs). Regulatory bodies like the FDA and EMA recognize gelatin as a safe and effective excipient when manufactured under strict quality controls and Good Manufacturing Practices (GMP). This endorsement strengthens its widespread use in both conventional and advanced drug delivery systems. As pharmaceutical innovation continues to grow, particularly in personalized medicine and complex therapies, gelatin's functional versatility is expected to further solidify its market position.

Key Market Challenges

Raw Material Supply and Price Volatility

The pharmaceutical gelatin market faces notable challenges due to the reliance on animal-derived raw materials such as bovine and porcine collagen. Factors like disease outbreaks (e.g., African swine fever), climate events, and fluctuating livestock populations can disrupt supply chains and elevate production costs. Environmental concerns, ethical considerations, and rising interest in alternative materials also add complexity to sourcing decisions. Additionally, raw material costs are sensitive to variables such as feed prices, transportation, and currency fluctuations, leading to inconsistent pricing. Meeting stringent regulatory requirements for pharmaceutical-grade gelatin adds further layers of cost and operational effort. These dynamics collectively pose risks to production stability and profitability, particularly for manufacturers operating in price-sensitive markets.

Key Market Trends

Shift Towards Plant-Based Alternatives

The rising demand for sustainable, cruelty-free, and allergen-friendly products is driving interest in plant-based alternatives to animal-derived pharmaceutical gelatin. These alternatives cater to growing vegan and vegetarian populations and meet religious or cultural dietary restrictions. They also present a more environmentally sustainable option, often requiring fewer natural resources and generating lower greenhouse gas emissions. Recent advancements in food and material science have enabled the development of plant-based gelling agents that mimic the functional properties of traditional gelatin. As pharmaceutical companies seek to diversify their excipient sources, plant-based gelatin substitutes are gaining attention for their potential to meet both functional and ethical criteria. However, achieving comparable performance and regulatory approval remains a focus of ongoing innovation.

Key Market Players

  • Gelita AG
  • Trobas Pharmaceutical gelatine B.V
  • Rousselot SAS
  • Gelatines Weishardt SAS
  • Sterling Biotec Ltd.
  • Catalent, Inc
  • Nitta Pharmaceutical Gelatin India Limited
  • Aspire Pharmaceuticals
  • Gelco International
  • Lapi Gelatine S.p.a

Report Scope:

In this report, the Global Pharmaceutical Gelatin Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pharmaceutical Gelatin Market, By Type:

  • Type A
  • Type B

Pharmaceutical Gelatin Market, By Source:

  • Porcine
  • Bovine Skin
  • Bovine Bone
  • Fish
  • Poultry

Pharmaceutical Gelatin Market, By Function:

  • Stabilizing
  • Thickening
  • Gelling
  • Others

Pharmaceutical Gelatin Market, By End User:

  • Hard Capsule
  • Soft Capsule
  • Tablet
  • Absorbable Hemostat
  • Others

Pharmaceutical Gelatin Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • South Korea
    • Australia
    • Japan
  • Europe
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Pharmaceutical Gelatin Market.

Available Customizations:

Global Pharmaceutical Gelatin Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Pharmaceutical Gelatin Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Type A, Type B)
    • 5.2.2. By Source (Porcine, Bovine Skin, Bovine Bone, Fish, Poultry)
    • 5.2.3. By Function (Stabilizing, Thickening, Gelling, Others)
    • 5.2.4. By End User (Hard Capsule, Soft Capsule, Tablet, Absorbable Hemostat, Others)
    • 5.2.5. By Company (2024)
    • 5.2.6. By Region
  • 5.3. Market Map

6. North America Pharmaceutical Gelatin Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Source
    • 6.2.3. By Function
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Pharmaceutical Gelatin Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Source
        • 6.3.1.2.3. By Function
        • 6.3.1.2.4. By End User
    • 6.3.2. Mexico Pharmaceutical Gelatin Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Source
        • 6.3.2.2.3. By Function
        • 6.3.2.2.4. By End User
    • 6.3.3. Canada Pharmaceutical Gelatin Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Source
        • 6.3.3.2.3. By Function
        • 6.3.3.2.4. By End User

7. Europe Pharmaceutical Gelatin Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Source
    • 7.2.3. By Function
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Pharmaceutical Gelatin Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Source
        • 7.3.1.2.3. By Function
        • 7.3.1.2.4. By End User
    • 7.3.2. Germany Pharmaceutical Gelatin Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Source
        • 7.3.2.2.3. By Function
        • 7.3.2.2.4. By End User
    • 7.3.3. United Kingdom Pharmaceutical Gelatin Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Source
        • 7.3.3.2.3. By Function
        • 7.3.3.2.4. By End User
    • 7.3.4. Italy Pharmaceutical Gelatin Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Source
        • 7.3.4.2.3. By Function
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Pharmaceutical Gelatin Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Source
        • 7.3.5.2.3. By Function
        • 7.3.5.2.4. By End User

8. Asia-Pacific Pharmaceutical Gelatin Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Source
    • 8.2.3. By Function
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Pharmaceutical Gelatin Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Source
        • 8.3.1.2.3. By Function
        • 8.3.1.2.4. By End User
    • 8.3.2. India Pharmaceutical Gelatin Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Source
        • 8.3.2.2.3. By Function
        • 8.3.2.2.4. By End User
    • 8.3.3. South Korea Pharmaceutical Gelatin Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Source
        • 8.3.3.2.3. By Function
        • 8.3.3.2.4. By End User
    • 8.3.4. Japan Pharmaceutical Gelatin Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Source
        • 8.3.4.2.3. By Function
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Pharmaceutical Gelatin Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Source
        • 8.3.5.2.3. By Function
        • 8.3.5.2.4. By End User

9. South America Pharmaceutical Gelatin Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Source
    • 9.2.3. By Function
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Pharmaceutical Gelatin Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Source
        • 9.3.1.2.3. By Function
        • 9.3.1.2.4. By End User
    • 9.3.2. Argentina Pharmaceutical Gelatin Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Source
        • 9.3.2.2.3. By Function
        • 9.3.2.2.4. By End User
    • 9.3.3. Colombia Pharmaceutical Gelatin Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Source
        • 9.3.3.2.3. By Function
        • 9.3.3.2.4. By End User

10. Middle East and Africa Pharmaceutical Gelatin Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Source
    • 10.2.3. By Function
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Pharmaceutical Gelatin Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Source
        • 10.3.1.2.3. By Function
        • 10.3.1.2.4. By End User
    • 10.3.2. Saudi Arabia Pharmaceutical Gelatin Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Source
        • 10.3.2.2.3. By Function
        • 10.3.2.2.4. By End User
    • 10.3.3. UAE Pharmaceutical Gelatin Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Source
        • 10.3.3.2.3. By Function
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Porters Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Gelita AG
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. Trobas Pharmaceutical gelatine B.V
  • 14.3. Rousselot SAS
  • 14.4. Gelatines Weishardt SAS
  • 14.5. Sterling Biotec Ltd.
  • 14.6. Catalent, Inc
  • 14.7. Nitta Pharmaceutical Gelatin India Limited
  • 14.8. Aspire Pharmaceuticals
  • 14.9. Gelco International
  • 14.10. Lapi Gelatine S.p.a

15. Strategic Recommendations

16. About Us & Disclaimer